BOSTON--(BUSINESS WIRE)--Infinata today announced the latest release of BioPharm Clinical, the leading tool to expedite study feasibility and clinical operations. This release features a completely ...

EDINBURGH, Scotland, March 23, 2022 /PRNewswire/ -- TC Biopharm (Holdings) PLC ("TC Biopharm" or the "Company") (NASDAQ: TCBP) (NASDAQ: TCBPW), a clinical stage biotechnology company developing ...

Recently, the first subject was enrolled and dosed in the Phase I clinical trial in China for GB10 Injection, an innovative ophthalmic drug independently developed by Shenzhen Kexing Pharmaceutical Co ...

TC BioPharm eliminated approximately 200 steps from its allogeneic CAR-T biomanufacturing process, reducing hands-on manufacturing time by half and cutting production costs to a fraction of the ...

TC BioPharm (TCBP) announced initiatives to outsource several functions, moving to a more decentralized model, resulting in reduction in its workforce. The initiatives focus on moving to a CDMO model ...

MIAMI--(BUSINESS WIRE)--Increased scrutiny and regulation in the nutraceutical and supplement market should be welcomed according to BioPharm CEO, Rafael Olartecoechea, producer of Vimulti® ...

EDINBURGH, Scotland, Sept. 13, 2022 /PRNewswire/ -- TC Biopharm (Holdings) PLC ("TC Biopharm" or the "Company") (NASDAQ: TCBP) (NASDAQ: TCBPW), a clinical stage biotechnology company developing ...

US biotech Dance Biopharm is to work with Phillips-Medisize, to develop a version of its inhaled insulin device that has data connectivity for better management of diabetes treatment. Inhaled insulin ...

ICICI Securities maintains ‘Add’ on Indegene; Sees 7% upside - Here's why (Photo source: X) Healthcare tech firm Indegene has announced the acquisition of BioPharm, a Pennsylvania-based specialised ...

BioPharm America is a unique partnering conference where the new wave of life science innovators partner to fuel the future of drug development. For the first time, this event will be held in Raleigh, ...

Shares of Sino Biopharmaceutical jumped after the Chinese pharma major said it plans to acquire Hangzhou Hygieia Biomedical. The stock rose as much as 5.5% on Wednesday morning in Hong Kong, and was ...